Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Vitamin E Cardiovascular Benefits Disputed In HOPE Study

This article was originally published in The Tan Sheet

Executive Summary

Long-term daily vitamin E supplementation has no apparent effect on cardiovascular outcomes in high-risk individuals 55 years and older, Heart Outcomes Prevention Evaluation Study (HOPE) investigators report in the Jan. 20 New England Journal of Medicine.

You may also be interested in...



Vitamin E and CVD

Natural source vitamin E (400 IU/day) has neutral effect on arterial plaque and other heart disease risk factors, subset study of Heart Outcomes Prevention Evaluation finds. "There were no differences in atherosclerosis progression rates between patients on vitamin E and those on placebo," SECURE study researchers Eva Lonn, MD, McMaster University, Hamilton, Ontario, et al. say in Feb. 20 issue of Circulation. The 732-patient Study to Evaluate Carotid Ultrasound Changes in Patients Treated with Ramipril and Vitamin E was part of the HOPE trial, which found similar results regarding the nutrient (1"The Tan Sheet" Jan. 24, 2000, p. 11)

Vitamin E and CVD

Natural source vitamin E (400 IU/day) has neutral effect on arterial plaque and other heart disease risk factors, subset study of Heart Outcomes Prevention Evaluation finds. "There were no differences in atherosclerosis progression rates between patients on vitamin E and those on placebo," SECURE study researchers Eva Lonn, MD, McMaster University, Hamilton, Ontario, et al. say in Feb. 20 issue of Circulation. The 732-patient Study to Evaluate Carotid Ultrasound Changes in Patients Treated with Ramipril and Vitamin E was part of the HOPE trial, which found similar results regarding the nutrient (1"The Tan Sheet" Jan. 24, 2000, p. 11)

Vitamin E and CVD

Natural source vitamin E (400 IU/day) has neutral effect on arterial plaque and other heart disease risk factors, subset study of Heart Outcomes Prevention Evaluation finds. "There were no differences in atherosclerosis progression rates between patients on vitamin E and those on placebo," SECURE study researchers Eva Lonn, MD, McMaster University, Hamilton, Ontario, et al. say in Feb. 20 issue of Circulation. The 732-patient Study to Evaluate Carotid Ultrasound Changes in Patients Treated with Ramipril and Vitamin E was part of the HOPE trial, which found similar results regarding the nutrient (1"The Tan Sheet" Jan. 24, 2000, p. 11)

Related Content

Topics

UsernamePublicRestriction

Register

PS090799

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel